Top Markets
Coin of the day
Creso Pharma Limited Creso Pharma Limited

Creso Pharma Limited

CPH
Rang in Aktien #30562
Creso Pharma Ltd. specializes in the development, registration, and... Creso Pharma Ltd. specializes in the development, registration, and commercialization of high-quality, pharmaceutical-grade cannabis and hemp-derived nutraceuticals. These health solutions are designed for both human and animal wellness, distributed across Europe, the Middle East, North America, and the Asia Pacific. The company also undertakes the creation and sale of therapeutic products, in addition to cultivating, processing, and supplying cannabis products to retail markets. Among its diverse product line are "anibidiol," a complementary feed for companion animals; "cannaQIX," a nutraceutical containing hemp oil extract, vitamins, and zinc, formulated to reduce stress and support psychological and nervous system functions; and topical skincare items like "cannaDOL," a CBD-based gel featuring a blend of cooling and warming essential oils. Creso Pharma Limited was founded in 2015 and operates from its headquarters in Nedlands, Australia.
Aktienkurs
$0.00634756
Zuletzt synchronisiert: 2023-06-09
Marktkapitalisierung
$16.30M
Veränderung (1 Tag)
5.01%
Veränderung (1 Jahr)
0.00%
Land
AU
Handel Creso Pharma Limited (CPH)

Kategorie

Dividendenrendite-Verlauf für Creso Pharma Limited (CPH)
Dividendenrendite (TTM) von Creso Pharma Limited (Aktienkürzel: CPH) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Creso Pharma Limited (CPH) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber